Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015: Elaboration and explanation

BMJ (Online)

Volumn 349, Issue , 2015, Pages

  Shamseer, Larissa ^a,v   Moher, David ^a,v   Clarke, Mike ^b   Ghersi, Davina ^c   Liberati, Alessandro ^d   Petticrew, Mark ^e   Shekelle, Paul ^f,ab   Stewart, Lesley A ^g,i   Altman, Douglas G ^h   Booth, Alison ⁱ   Chan, An Wen ^j   Chang, Stephanie ^k   Clifford, Tammy ^l   Dickersin, Kay ^m   Egger, Matthias ⁿ   Gøtzsche, Peter C ^o   Grimshaw, Jeremy M ^a   Groves, Trish ^p   Helfand, Mark ^q   Higgins, Julian ^r   Lasserson, Toby ^s   Lau, Joseph ^t   Lohr, Kathleen ^u   McGowan, Jessie ^v   Mulrow, Cynthia ^w   Norton, Melissa ^x   Page, Matthew ^y   Sampson, Margaret ^z   Schünemann, Holger ^aa   Simera, Iveta ^h   Summerskill, William ^ac   Tetzlaff, Jennifer ^a   Trikalinos, Thomas A ^t   Tovey, David ^ad   Turner, Lucy ^a   Whitlock, Evelyn ^ae   more..

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f Southern California Evidence Based Practice Center   (Canada)

^g UNIVERSITY OF YORK   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ UNIVERSITY OF YORK   (United Kingdom)

^j UNIVERSITY OF TORONTO   (Canada)

^k AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^l CANADIAN AGENCY FOR DRUGS AND TECHNOLOGIES IN HEALTH   (Canada)

^m JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ UNIVERSITY OF ZURICH   (Switzerland)

^o Nordic Cochrane Centre   (Denmark)

^p BMJ   (United Kingdom)

^q Portland VA Research Foundation   (United States)

^r MRC Centre for Causal Analyses in Translational Epidemiology (CAiTE)   (United Kingdom)

^s School of Social and Community Medicine ^*  (United Kingdom)

^t BROWN UNIVERSITY   (United States)

^u RTI INTERNATIONAL   (United States)

^v UNIVERSITY OF OTTAWA   (Canada)

^w Annals of Internal Medicine   (United States)

^x OHRI and University of Ottawa ^*  (United Kingdom)

^y MONASH UNIVERSITY   (Australia)

^z CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^aa MCMASTER UNIVERSITY   (Canada)

^ab Southern California EPC   (United States)

^ac THE LANCET   (United Kingdom)

^ad The Cochrane Library   (United Kingdom)

^ae KAISER PERMANENTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CHECKLIST; CLINICAL DECISION MAKING; DOCUMENTATION; HEALTH CARE; HEALTH CARE POLICY; INFORMATION PROCESSING; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PRISMA P CHECKLIST; REGISTER; REVIEW; SYSTEMATIC REVIEW (TOPIC); ACCESS TO INFORMATION; LITERATURE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PUBLISHING; QUALITY CONTROL; RESEARCH; STANDARDS;

ACCESS TO INFORMATION; GUIDELINE ADHERENCE; META-ANALYSIS AS TOPIC; PUBLISHING; QUALITY CONTROL; RESEARCH DESIGN; RESEARCH REPORT; REVIEW LITERATURE AS TOPIC;

EID: 84920843179     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g7647     Document Type: Review

References (186)

1. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 2007;4:e78.
2. Dwan K, Gamble C, Williamson PR, Kirkham JJ. Systematic review of the empirical evidence of study publication bias and outcome reporting bias-An updated review. PloS One 2013;8:e66844.
3. Dwan K, Altman DG, Cresswell L, Blundell M, Gamble CL, Williamson PR. Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst Rev 2011;(1):MR000031.
4. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365.
5. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008;3:e3081.
6. Chan AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the canadian institutes of health research. Can Med Assoc J 2004;171:735.
7. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 2004;291:2457-65.
8. Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, et al. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions . Cochrane Library, 2014.
9. Page MJ, McKenzie JE, Forbes A. Many scenarios exist for selective inclusion and reporting of results in randomized trials and systematic reviews. J Clin Epidemiol 2013;66:524-37.
10. Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process. PLoS One 2010;5:e9810.
11. Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. Establishing a minimum dataset for prospective registration of systematic reviews: An international consultation. PLoS One 2011;6:e27319.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009;339:b2535.
13. Chan A, Tetzlaff JM, Gøtzsche PS, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: Guidance for protocols of clinical trials. BMJ 2013;346:e7586.
14. Institute of Medicine. Finding what works in health care: standards for systematic reviews . National Academies Press, 2011.
15. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1.
16. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7:e1000217.
17. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
18. Enhancing reproducibility. Nature Methods 2013;10:367.
19. Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, et al. PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med 2013;10:e1001419.
20. Mans CM, Reeve JC, Gasparini CA, Elkins MR. Postoperative outcomes following preoperative inspiratory muscle training in patients undergoing open cardiothoracic or upper abdominal surgery: protocol for a systematic review. Syst Rev 2012;1:63.
21. Wen J, Ren Y, Wang L, Li Y, Liu Y, Zhou M, et al. The reporting quality of meta-analyses improves: a random sampling study. J Clin Epidemiol 2008;61:770.
22. Moher D, Booth A, Stewart L. How to reduce unnecessary duplication: Use PROSPERO. BJOG 2014;121:784-6.
23. Montori VM, Wilczynski NL, Morgan D, Haynes RB. Optimal search strategies for retrieving systematic reviews from medline: analytical survey. BMJ 2005;330:68.
24. O'Connor AM, Auvermann BW, Higgins JP, Kirychuk SP, Sargeant JM, Von Essen SG, et al. The association between proximity to animal-feeding operations and community health: a protocol for updating a systematic review. Syst Rev 2014;3:99.
25. Moher D, Tsertsvadze A. Systematic reviews: When is an update an update? Lancet 2006;367:881-3.
26. Shojania KG, Sampson M, Ansari MT, Ji J, Doucette S, Moher D. How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med 2007;147:224-33.
27. Moher D, Tsertsvadze A, Tricco AC, Eccles M, Grimshaw J, Sampson M, et al. A systematic review identified few methods and strategies describing when and how to update systematic reviews. J Clin Epidemiol 2007;60:1095.
28. Garritty C, Tsertsvadze A, Tricco AC, Sampson M, Moher D. Updating systematic reviews: an international survey. PloS One 2010;5:e9914.
29. Chung M, Newberry SJ, Ansari MT, Yu WW, Wu H, Lee J, et al. Two methods provide similar signals for the need to update systematic reviews. J Clin Epidemiol 2012;65:660-8.
30. Ahmadzai N, Newberry SJ, Maglione MA, Tsertsvadze A, Ansari MT, Hempel S, et al. A surveillance system to assess the need for updating systematic reviews. Syst Rev 2013;2:1-16.
31. Chalmers I, Enkin M, Keirse MJ. Preparing and updating systematic reviews of randomized controlled trials of health care. Milbank Q 1993:411-37.
32. Cancelliere C, Cassidy JD, Côté P, Hincapié CA, Hartvigsen J, Carroll LJ, et al. Protocol for a systematic review of prognosis after mild traumatic brain injury: an update of the WHO collaborating centre task force findings. Syst Rev 2012;1:17.
33. Stewart L, Moher D, Shekelle P. Why prospective registration of systematic reviews makes sense. Syst Rev 2012;1:7.
34. Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic-review protocols. Lancet 2011;377:108-9.
35. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: An international prospective register of systematic reviews. Syst Rev 2012;1:2.
36. Silagy CA, Middleton P, Hopewell S. Publishing protocols of systematic reviews: comparing what was done to what was planned. JAMA 2002;287:2831-4.
37. Siontis KC, Hernandez-Boussard T, Ioannidis JP. Overlapping meta-analyses on the same topic: survey of published studies. BMJ 2013;347:f4501.
38. Moher D. The problem of duplicate systematic reviews. BMJ 2013;347:f5040.
39. The PLoS ME. Best practice in systematic reviews: the importance of protocols and registration. PLoS Med 2011;8:e1001009.
40. Chien PFW, Khan KS, Siassakos D. Registration of systematic reviews: PROSPERO. BJOG 2012;119:903-5.
41. Bambra C, Hillier F, Moore H, Summerbell C. Tackling inequalities in obesity: a protocol for a systematic review of the effectiveness of public health interventions at reducing socioeconomic inequalities in obesity amongst children. Syst Rev 2012;1:16.
42. Mowatt G, Shirran L, Grimshaw JM, Rennie D, Flanagin A, Yank V, et al. Prevalence of honorary and ghost authorship in cochrane reviews. JAMA 2002;287:2769-71.
43. Rennie D, Yank V, Emanuel L. When authorship fails. JAMA 1997;278:579-85.
44. Sismondo S. Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? PLoS Med 2007;4:e286.
45. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib. JAMA 2008;299:1800-12.
46. Smith R. Maintaining the integrity of the scientific record. BMJ 2001;323:588.
47. Ensor J, Riley RD, Moore D, Bayliss S, Jowett S, Fitzmaurice DA. Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE. Syst Rev 2013;2:91.
48. Smith R. Authorship is dying: long live contributorship. BMJ 1997;315:696.
49. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2010. www.ICMJE.org.
50. AHRQ Agency for Healthcare Research and Quality, Effective Health Care Program. Research protocol-Apr 3, 2014: Treatments for fibromyalgia in adult subgroups. http:// effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/? pageaction=displayproduct&productid=1887#8696.
51. AHRQ Agency for Healthcare Research and Quality, Effective Health Care Program. Research Protocol-Jul 21, 2014: Treatment of non-metastatic muscle-invasive bladder cancer. http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/? pageaction=displayproduct&productid=1940#9004.
52. Getz KA, Zuckerman R, Cropp AB, Hindle AL, Krauss R, Kaitin KI. Measuring the incidence, causes, and repercussions of protocol amendments. Drug Inf J 2011;45:265-75.
53. Higgins JPT, Green S, eds. Guide to the contents of a Cochrane protocol and review. In: The Cochrane handbook for systematic reviews of interventions . Wiley-Blackwell, 2011.
54. Young M, Stevens A, Porath-Waller A, Pirie T, Garritty C, Skidmore B, et al. Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review protocol. Syst Rev 2012;1:22.
55. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev 2012;(12):MR000033.
56. Bero L. Industry sponsorship and research outcome: a cochrane review. JAMA Intern Med 2013;173:580-1.
57. Roseman M, Turner EH, Lexchin J, Coyne JC, Bero LA, Thombs BD. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ 2012;345:e5155.
58. Jorgensen AW, Hilden J, Gotzsche PC. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006;333:782.
59. Yank V, Rennie D, Bero LA. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. BMJ 2007;335:1202-5.
60. Jorgensen AW, Maric KL, Tendal B, Faurschou A, Gotzsche PC. Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions. BMC Med Res Methodol 2008;8:60.
61. Bes-Rastrollo M, Schulze MB, Ruiz-Canela M, Martinez-Gonzalez MA. Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: A systematic review of systematic reviews. PLoS Med 2013;10:e1001578.
62. Rochon PA, Hoey J, Chan A, Ferris LE, Lexchin J, Kalkar SR, et al. Financial conflicts of interest checklist 2010 for clinical research studies. Open Med 2010;4:e69.
63. Holden MA, Haywood KL, Potia TA, Gee M, McLean S. Recommendations for exercise adherence measures in musculoskeletal settings: a systematic review and consensus meeting (protocol). Syst Rev 2014;3:1-6.
64. Founti P, Topouzis F, Anastasopoulos E, Pappas T, Lambropoulos A, Chatzikyriakidou A, et al. Association of LOXL1 polymorphisms with pseudoexfoliation syndrome and pseudoexfoliative glaucoma: systematic review and meta-analysis. PROSPERO:CRD42014009228. www.crd.york.ac.uk/PROSPERO/display-record.asp? ID=CRD42014009228.
65. CDISC Clinical Data Interchange Standards Consortium. CDISC Clinical Research Glossary . 2011. www.cdisc.org/stuff/contentmgr/files/0/08a36984bc61034baed3b019f3a87139/misc/act1211-011-043-gr-glossary.pdf.
66. Hayden J, Cartwright J, Riley R, vanTulder M. Exercise therapy for chronic low back pain: Protocol for an individual participant data meta-analysis. Syst Rev 2012;1:64.
67. Moseley AM, Elkins MR, Herbert RD, Maher CG, Sherrington C. Cochrane reviews used more rigorous methods than non-cochrane reviews: survey of systematic reviews in physiotherapy. J Clin Epidemiol 2009;62:1021-30.
68. Psaty BM, Kronmal RA. Reporting mortality findings in trials of rofecoxib for alzheimer disease or cognitive impairment: A case study based on documents from rofecoxib litigation. JAMA 2008;299:1813-7.
69. Cohen D. Rosiglitazone: What went wrong? BMJ 2010;341:c4848.
70. Chung A, Backholer K, Wong E, Palermo C, Keating C, Peeters A. Trends in child and adolescent obesity prevalence according to socioeconomic position: Protocol for a systematic review. Syst Rev 2014;3:1-4.
71. Moher D, Tsertsvadze A, Tricco AC, Eccles MG, J., Sampson M, Barrowman N. A systematic review identified few methods and strategies describing when and how to update systematic reviews. J Clin Epidemiol 2007;60:1095.
72. Eipe N, Penning J, Ansari M, Yazdi F, Ahmadzai N. A protocol for a systematic review for perioperative pregabalin use. Syst Rev 2012;1:40.
73. Honein-Abouhaidar GN, Kastner M, Vuong V, Perrier L, Rabeneck L, Tinmouth J, et al. Benefits and barriers to participation in colorectal cancer screening: A protocol for a systematic review and synthesis of qualitative studies. BMJ Open 2014;4:e004508.
74. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med 1997;127:380-7.
75. Whitlock EP, Lopez SA, Chang S, Helfand M, Eder M, Floyd N. AHRQ series paper 3: Identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health-care program. J Clin Epidemiol 2010;63:491.
76. Hamel C, Stevens A, Singh K, Ansari MT, Myers E, Ziegler P, et al. Do sugar-sweetened beverages cause adverse health outcomes in adults? A systematic review protocol. Syst Rev 2014;3:108.
77. Higgins JPT and Green S, eds. Cochrane handbook for systematic reviews of interventions . version 5.0.2. Cochrane Collaboration, 2009.
78. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. rating the quality of evidence-publication bias. J Clin Epidemiol 2011;64:1277-82.
79. Adams D, Wu T, Yasui Y, Aung S, Vohra S. Systematic reviews of TCM trials: How does inclusion of Chinese trials affect outcome? J Evid Based Med 2012;5:89-97.
80. Hopewell S, McDonald S, Clarke Mike J, Egger M. Grey literature in meta-analyses of randomized trials of health care interventions . John Wiley & Sons, 2007.
81. Van Enst WA, Scholten RJPM, Hooft L. Identification of additional trials in prospective trial registers for cochrane systematic reviews. PloS One 2012;7:e42812.
82. Tricco A, Chit A, Hallett D, Soobiah C, Meier G, Chen M, et al. Effect of influenza vaccines against mismatched strains: A systematic review protocol. Syst Rev 2012;1:35.
83. Horsley T, Dingwall O, Sampson M. Checking reference lists to find additional studies for systematic reviews. Cochrane Database Syst Rev 2011;(8):MR000026.
84. Zhang L, Sampson M, McGowan J. Reporting of the role of the expert searcher in cochrane reviews. Evid Based Libr Inf Pract 2006;1:3-16.
85. Lefebvre C, Manheimer E, Glanville J, Cochrane Information Retrieval Methods Group. Searching for studies. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions . 5.1.0 ed. Cochrane Collaboration, 2011.
86. Relevo R, Balshem H. Finding evidence for comparing medical interventions. In: Methods guide for effectiveness and comparative effectiveness reviews . AHRQ Publication No 10(12)-EHC063-EF. Agency for Healthcare Research and Quality, 2012.
87. Daboval T, Ward N, Sampson M, Kharrat A. Antenatal counseling about the perinatal care plan at the limit of viability: What do parents want? A systematic review protocol. (unpublished).
88. McGowan J, Sampson M, Lefebvre C. An evidence based checklist for the peer review of electronic search strategies (PRESS EBC). Evid Based Libr Inf Pract 2010;5:149-54.
89. Deeks JJ, Altman DG. Inadequate reporting of controlled trials as short reports. Lancet 1998;352:1908.
90. Iansavichene AE, Sampson M, McGowan J, Ajiferuke ISY. Should systematic reviewers search for randomized, controlled trials published as letters? Ann Intern Med 2008;148:714-5.
91. Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol 2009;62:944-52.
92. Elamin MB, Flynn DN, Bassler D, Briel M, Alonso-Coello P, Karanicolas PJ, et al. Choice of data extraction tools for systematic reviews depends on resources and review complexity. J Clin Epidemiol 2009;62:506-10.
93. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Impact of covert duplicate publication on meta-analysis: a case study. BMJ 1997;315:635-40.
94. Von Elm E, Poglia G, Walder B, Tramer MR. Different patterns of duplicate publication. JAMA 2004;291:974-80.
95. Gøtzsche P. Multiple publication of reports of drug trials. Eur J Clin Pharmacol 1989;36:429-32.
96. Macdonald G, McCartan CJ. Centre-based early education interventions for improving school readiness. Cochrane Database Syst Rev 2014;(1):CD010913.
97. Edwards P, Clarke M, DiGuiseppi C, Pratap S, Roberts I, Wentz R. Identification of randomized controlled trials in systematic reviews: Accuracy and reliability of screening records. Stat Med 2002;21:1635-40.
98. Cooper H, Ribble RG. Influences on the outcome of literature searches for integrative research reviews. Sci Commun 1989;10:179-201.
99. Busse JW, Ebrahim S, Connell G, Coomes EA, Bruno P, Malik K, et al. Systematic review and network meta-analysis of interventions for fibromyalgia: A protocol. Syst Rev 2013;2:18.
100. Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP. Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol 2006;59:697-703.
101. Horton J, Vandermeer B, Hartling L, Tjosvold L, Klassen TP, Buscemi N. Systematic review data extraction: Cross-sectional study showed that experience did not increase accuracy. J Clin Epidemiol 2010;63:289-98.
102. Jones AP, Remmington T, Williamson PR, Ashby D, Smyth RL. High prevalence but low impact of data extraction and reporting errors were found in cochrane systematic reviews. J Clin Epidemiol 2005;58:741-2.
103. Shadish WR, Brasil ICC, Illingworth DA, White KD, Galindo R, Nagler ED, et al. Using UnGraph to extract data from image files: Verification of reliability and validity. Behav Res Methods 2009;41:177-83.
104. Stewart LA. Practical methodology of meta?analyses (overviews) using updated individual patient data. Stat Med 2007;14:2057-79.
105. Clarke M, Hopewell S, Juszczak E, Eisinga A, Kjeldstrom M. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database Syst Rev 2006;(2):CD004002.
106. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ 2008;336:1472.
107. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Med 2010;8:18.
108. Higgins JPT, Deeks JJ. Selecting studies and collecting data. In: Higgins JPT, Green S, eds. The Cochrane handbook for systematic reviews of interventions. 5.1.0 ed. Cochrane Collaboration, 2011.
109. Errami M, Sun Z, Long TC, George AC, Garner HR. Deja vu: A database of highly similar citations in the scientific literature. Nucleic Acids Res 2009;37(suppl 1):D921-4.
110. Reichenbach S, Rutjes AWS, Nüesch E, Trelle S, Jüni P. Arthroscopic lavage for osteoarthritis of the knee. Cochrane Library. 2008, 10.1002/14651858.CD007320.
111. Tully PJ, Baumeister H. Collaborative care for the treatment of comorbid depression and coronary heart disease: A systematic review and meta-analysis protocol. Syst Rev 2014;3:127.
112. Dwan K, Gamble C, Kolamunnage-Dona R, Mohammed S, Powell C, Williamson P. Assessing the potential for outcome reporting bias in a review: A tutorial. Trials 2010;11:52.
113. Leucht C, Huhn M, Leucht S. Amitriptyline versus placebo for major depressive disorder (protocol). Cochrane Database Syst Rev 2011;(5):CD009138.
114. Helfand M, Balshem H. AHRQ series paper 2: Principles for developing guidance: AHRQ and the effective health-care program. J Clin Epidemiol 2010;63:484.
115. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991;14:540-5.
116. Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep 1992;15:376-81.
117. Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA 2012;307:1583-4.
118. Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). Methodological standards and patient-centeredness in comparative effectiveness research: The PCORI perspective. JAMA 2012;307:1636-40.
119. Cordoba G, Schwartz L, Woloshin S, Bae H, Gotzsche PC. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ 2010;341:c3920.
120. Page MJ, McKenzie JE, Forbes A. Many scenarios exist for selective inclusion and reporting of results in randomized trials and systematic reviews. J Clin Epidemiol 2013;66:524-37.
121. Hosseini Araghi M, Chen YF, Jagielski A, Mannan Choudhury S, Banerjee D, Thomas GN, et al. Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults (protocol). Cochrane Database Syst Rev 2012;(12):CD010281.
122. Lawley CM, Lain SJ, Algert CS, Ford JB, Figtree GA, Roberts CL. Prosthetic heart valves in pregnancy: A systematic review and meta-analysis protocol. Syst Rev 2014;3:8.
123. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
124. Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters M, et al. Assessing the risk of bias of individual studies in systematic reviews of health care interventions. AHRQ Methods for Effective Health Care 2012 Mar 08.
125. Hartling L, Hamm MP, Milne A, Vandermeer B, Santaguida PL, Ansari M, et al. Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. J Clin Epidemiol 2013;66:973-81.
126. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
127. Berlin JA. Does blinding of readers affect the results of meta-analyses? Lancet 1997;350:185-6.
128. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews: Results of the meta-quality cross sectional study. BMJ 2005;330:1053.
129. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. BMJ 2008;336:601-5.
130. Savoviæ J, Harris RJ, Wood L, Beynon R, Altman D, Als-Nielsen B, et al. Development of a combined database for meta-epidemiological research. Res Synth Methods 2011;2:78.
131. Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P. Single-center trials show larger treatment effects than multicenter trials: Evidence from a meta-epidemiologic study. Ann Intern Med 2011;155:39.
132. Odgaard-Jensen J, Vist G, Timmer A, Kunz R, Akl E, Schünemann H, et al. Randomised controlled trials as a safeguard against biased estimates of treatment effects. Cochrane Database Syst Rev 2011;(4):MR000012.
133. Sanderson S, Tatt ID, Higgins JPT. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography. Int J Epidemiol 2007;36:666-76.
134. Dechartres, A. Charles, P. Hopewell, S. Ravaud, P. Altman, D.G. Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed. J Clin Epidemiol 2011;64:136-44.
135. Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.
136. Ioannidis JPA, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-30.
137. Savovic J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 2012;157:429-38.
138. Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomised clinical trials with binary outcomes: Systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012;344:e1119.
139. Bell ML, Kenward MG, Fairclough DL, Horton NJ. Differential dropout and bias in randomised controlled trials: When it matters and when it may not. BMJ 2013;346:e8668.
140. Guyatt GH, Briel M, Glasziou P, Bassler D, Montori VM. Problems of stopping trials early. BMJ 2012;344:e3863.
141. Briel M, Bassler D, Wang AT, Guyatt GH, Montori VM. The dangers of stopping a trial too early. J Bone Joint Surg 2012;94(suppl 1):56-60.
142. DeAngelis CD FP. Impugning the integrity of medical science: The adverse effects of industry influence. JAMA 2008;299:1833-5.
143. Kahan BC, Morris TP. Analysis of multicentre trials with continuous outcomes: When and how should we account for centre effects? Stat Med 2013;32:1136-49.
144. Shephard RJ. Ethics in exercise science research. Sports Med 2002;32:169-83.
145. Fanelli D. How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One 2009;4:e5738.
146. Higgins J, Ramsay C, Reeves BC, Deeks JJ, Shea B, Valentine JC, et al. Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Res Synth Methods 2012.
147. Mao C, Yang ZY, Chung VCH, Qin Y, Tam W, Kwong JSW, et al. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention. Cochrane Library 2012.
148. Villar J, Mackey ME, Carroli G, Donner A. Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: Comparison of fixed and random effects models. Stat Med 2001;20:3635-47.
149. Hunter JE, Schmidt FL. Fixed effects vs. random effects meta-analysis models: implications for cumulative research knowledge. Int J Select Assess 2002;8:275-92.
150. Schmidt FL, Oh IS, Hayes TL. Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol 2009;62:97-128.
151. Higgins J, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
152. Higgins JPT, Deeks JJ, Altman DG. Special topics in statistics. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions . 5.1.0 ed. Cochrane Collaboration, 2011.
153. Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, et al. PRISMA-IPD: an extension to the PRISMA statement guidance for reporting systematic review and meta-analysis of individual participant data. (submitted).
154. Thiessen PH, Barrowman N, Garg A. Imputing variance estimates do not alter the conclusions of a meta-analysis with continuous outcomes: A case study of changes in renal function after living kidney donation. J Clin Epidemiol 2007;60:228.
155. Stevens JW. A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS. Pharmaceut Stat 2011;10:374-8.
156. Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ. A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol 2006;59:342-53.
157. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 2006;59:7.
158. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16.
159. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-5.
160. Whitehead PJ, Drummond AE, Walker MF, Parry RH. Interventions to reduce dependency in personal activities of daily living in community-dwelling adults who use homecare services: protocol for a systematic review. Syst Rev 2013;2:1-7.
161. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O, Peacock R. Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review. Soc Sci Med 2005;61:417-30.
162. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. a product from the ESRC methods programme. Version 1. ESRC, 2006.
163. Richards BL, Whittle SL, Buchbinder R. Neuromodulators for pain management in rheumatoid arthritis (protocol). Cochrane Database Syst Rev 2011;(1):CD008921.
164. Goodman S, Dickersin K. Metabias: A challenge for comparative effectiveness research. Ann Intern Med 2011;155:61-2.
165. Song F, Parekh S, Hooper L, Loke Y, Ryder J, Sutton A, et al. Dissemination and publication of research findings: an updated review of related biases . Prepress Projects, 2010.
166. Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:302.
167. Terrin N, Schmid CH, Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol 2005;58:894-901.
168. Lau J, Ioannidis J, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006;333:597-600.
169. Parekh-Bhurke S, Kwok CS, Pang C, Hooper L, Loke YK, Ryder JJ, et al. Uptake of methods to deal with publication bias in systematic reviews has increased over time, but there is still much scope for improvement. J Clin Epidemiol 2011;64:349-57.
170. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60.
171. Turner EH, Knoepflmacher D, Shapley L. Publication bias in antipsychotic trials: An analysis of efficacy comparing the published literature to the us food and drug administration database. PLoS Med 2012;9:e1001189.
172. Williamson P, Gamble C, Altman D, Hutton J. Outcome selection bias in meta-analysis. Stat Methods Med Res 2005;14:515-24.
173. Chan AW, Altman DG. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 2005;330:753.
174. Williamson PR, Gamble C. Application and investigation of a bound for outcome reporting bias. Trials 2007;8:9.
175. th Campbell Colloquium; Oct 18-22; Keystone, Colorado; 2010.
176. Hart B, Lundh A, Bero L. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ 2012;344:d7202.
177. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1.Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383-94.
178. Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coello P, et al. GRADE guidelines. 11: Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol 2013;66:151-7.
179. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. treatments for myocardial infarction. JAMA 1992;268:240-8.
180. Oxman AD, Guyatt GH. The science of reviewing research. Ann N Y Acad Sci 1993;703:125.
181. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990;263:1385-9.
182. Begg CB. Publication bias: A problem in interpreting medical data. J R Stat Soc A 1988;151:419-63.
183. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009;(1):MR000006.
184. Dickersin K, Chalmers I. Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO. J R Soc Med 2011;104:532-8.
185. Dickersin K. Publication bias: recognizing the problem, understanding its origins and scope, and preventing harm. In: Rothstein HR, Sutton AJ, Borenstein M, eds. Publication bias in meta-analysis-Prevention, assessment and adjustments . John Wiley & Sons, 2005:11-33.
186. Williamson PR, Gamble C, Altman DG, Hutton JL. Outcome selection bias in meta-analysis. Stat Methods Med Res 2005;14:515-24.